Related Experiment Videos
Microarray analysis of VEGF-C responsive genes in human lymphatic endothelial cells
Carolyn Yong1, Eric A Bridenbaugh, David C Zawieja
1Integrative Biosciences Institute, Ecole Polytechnique Fédérale de Lausanne (EPFL), CH-1015 Lausanne, Switzerland.
Lymphatic Research and Biology
|December 29, 2005
Summary
Vascular endothelial growth factor-C (VEGF-C) significantly alters gene expression in lymphatic endothelial cells (LECs). This response impacts cell cycle, angiogenesis, and notably, lipid metabolism and neurogenesis pathways.
Area of Science:
- Molecular Biology
- Cell Biology
- Genomics
Background:
- Vascular endothelial growth factor-C (VEGF-C) is a key regulator of lymphatic endothelial cell (LEC) biology.
- Understanding VEGF-C's impact on LECs is crucial for lymphangiogenesis and related diseases.
Purpose of the Study:
- To comprehensively characterize the gene expression profile of human microvascular LECs in response to VEGF-C stimulation.
- To identify novel pathways and genes regulated by VEGF-C in LECs.
Main Methods:
- Primary human microvascular LECs were treated with VEGF-C (100 ng/mL) for 30 minutes and 6 hours.
- Microarray analysis was employed to assess genome-wide mRNA expression changes.
Main Results:
- VEGF-C induced significant changes in gene expression, predominantly affecting transcription factors and cell cycle-related genes.
- Genes involved in angiogenesis, tumorigenesis, tumor invasion, and transport processes were modulated.
- Notably, genes associated with lipid metabolism, neurogenesis, and neurodegeneration also showed responsiveness to VEGF-C.
Conclusions:
- VEGF-C elicits a complex transcriptional response in LECs, extending beyond canonical lymphangiogenesis pathways.
- The identified gene expression changes offer insights into VEGF-C's role in pathogenesis and suggest potential new functions.
- Further investigation into VEGF-C-responsive genes could illuminate mechanisms in lymphangiogenesis and associated disorders.